Charles Weijer BMdSc, MD Alberta; BA(Hons), MSc, PhD McGill Phone: 519-661-2111 ext. 80090 Email: cweijer@uwo.ca Website: www.rotman.uwo.ca Professor Weijer is on sabbatical leave until June 30, 2013. Selected Publications Books Corrigan O, Liddell K, McMillan J, Richards M, Weijer C (eds.). Limits of Consent: A Socio-ethical Approach to Human Subjects Research in Medicine. Oxford: Oxford University Press, 2009. Articles Gallo A, Weijer C, White A, Grimshaw JM, Baruch R, Brehaut JC, Donner A, Eccles MP, McRae AD, Saginur R, Zwarenstein M, Taljaard M. What is the role and authority of gatekeepers in cluster randomized trials in health research? Trials 2012, in press. McRae AD, Weijer C, Binik A, et al.. When is informed consent required in cluster randomized trials in health research? Trials 2011; 12: 202. Ivers N, Taljaard M, Dixon S, Bennett C, McRae A, Taleban J, Skea Z, Brehaut J, Boruch RF, Eccles M, Grimshaw JM, Weijer C, Zwarenstein M, Donner A. Impact of the CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of a random sample of 300 trials from 2000 to 2008. British Medical Journal 2011; 343: d5886. McRae AD, Weijer C, Binik A, et al.. Who is the research subject in cluster randomized trials? Trials 2011; 12: 183. Binik A, Weijer C, McRae AD, et al.. Does clinical equipoise apply to cluster randomized trials in health research? Trials 2011: 12: 118. Weijer C, Grimshaw JM, Taljaard M, Binik A, Boruch R, Brehaut JC, Donner A, Eccles MP, Gallo A, McRae AD, Saginur R, Zwarenstein M. Ethical issues posed by cluster randomized trials in health research. Trials 2011; 12: 100. Taljaard M, McRae A, Weijer C, et al.. Inadequate reporting of research ethics review and informed consent in cluster randomized trials: review of a representative sample of published trials. British Medical Journal 2011; 342: d2496. Kimmelman J, Weijer C, Meslin EM. Helsinki discords: FDA, ethics, and international drug trials. Lancet 2009; 373(9657): 13–4. Miller PB, Weijer C. Equipoise and the duty of care in clinical research: a philosophical response to our critics. Journal of Medicine and Philosophy 2007; 32(2): 117–33. Miller PB, Weijer C. Fiduciary obligation in clinical research. Journal of Law, Medicine & Ethics 2006; 34(2): 424–40. Miller PB, Weijer C. The trust-based obligations of the state and physician-researchers to patient-subjects. Journal of Medical Ethics 2006; 32(9): 542–7. Weijer C, LeBlanc GJ. The balm of Gilead: is the provision of treatment to those who seroconvert in HIV prevention trials a matter of moral obligation or moral negotiation? Journal of Law, Medicine & Ethics 2006; 34(4): 793–808. Book Chapters Weijer C, Lanata CF, Plowe CV. Ethical considerations in the conduct of vaccine trials in developing countries. In: Levine MM, Dougan G, Good MF, Liu MA, Nabel GJ, Nataro JP, Rappuoli R (eds.). New Generation Vaccines (4th edition). New York: Informa Health Care, Inc., 2010: 59–65. Miller PB, Weijer C. Evaluating benefits and harms in clinical research. In: Ashcroft R, Dawson A, Draper H, McMillan J (eds.). Principles of Health Care Ethics (2nd ed.). London: John Wiley & Sons, 2007: 711–717.Contact Directory
Menu
Contact Us
Rhena Makeiff
Graduate Program Assistant (Acting)
Carolyn McLeod
Graduate Program Chair
Corey Dyck
Graduate Placement Officer
Henrik Lagerlund
Department Chair



